IBD 50 Stocks To Watch: This Biotech Stock With 282% Earnings Growth Nears Buy Point

2021-03-31T19:39:43-04:00March 31st, 2021|

Meridian Bioscience is the IBD 50 Stocks To Watch pick for Wednesday. It is eyeing a new buy point. VIVO stock has ran as much as 456% above its 2020 lows.
Read More

share this article!

IBD 50 Stocks To Watch: This Biotech Stock With 282% Earnings Growth Nears Buy Point

Related Posts

Pfizer Receives FDA Approval for Bleeding Disorder Treatment, Go to article

ResMed Stock Soars After Strong Earnings. Wall Street Thinks It Can Do Even Better., Go to article

Meta, Netflix and 2 Other Stocks May Be Bargains After Post-Earnings Slides, Go to article

Back Off, Stagflation. This Stock Rally Isn’t Over Yet., Go to article